Regencell Bioscience Holdings Stock Performance
| RGC Stock | USD 28.28 3.29 13.17% |
Regencell Bioscience holds a performance score of 12 on a scale of zero to a hundred. The company holds a Beta of 2.03, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Regencell Bioscience will likely underperform. Use Regencell Bioscience jensen alpha, potential upside, accumulation distribution, as well as the relationship between the treynor ratio and expected short fall , to analyze future returns on Regencell Bioscience.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Regencell Bioscience Holdings are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent technical and fundamental indicators, Regencell Bioscience exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 13.17 | Five Day Return (10.17) | Year To Date Return 37.68 | Ten Year Return (52.87) | All Time Return (52.87) |
Last Split Factor 38:1 | Last Split Date 2025-06-16 |
1 | DOJ Probe and Legal Risks Might Change The Case For Investing In Regencell Bioscience Holdings | 11/21/2025 |
2 | Regencell Bioscience Shares Gap Up - Still a Buy - MarketBeat | 01/02/2026 |
3 | IBD Rating Upgrades Regal Rexnord Flashes Improved Technical Strength | 01/07/2026 |
4 | Regencell Bioscience Shares Gap Up Heres What Happened | 01/08/2026 |
5 | US Stock Market Today SP 500 Futures Ease On Cooling Jobs And Strong Tech Trade | 01/09/2026 |
6 | Regal Partners Anticipates 145 Million Net Profit | 01/12/2026 |
7 | XOXO, Regal Delivers a Month-Long Love Letter to Moviegoers in February | 01/15/2026 |
8 | Regencell Bioscience Trading Down 7.8 percent - Whats Next - MarketBeat | 01/20/2026 |
9 | Regencell Bioscience Holdings Is Up 6.5 percent After Valuation Surges Despite DOJ Probe And No Revenue | 01/27/2026 |
10 | Regencell Bioscience Shares Gap Down Heres What Happened | 01/29/2026 |
11 | Regencell Bioscience Trading Up 12.6 percent Should You Buy | 02/02/2026 |
| Begin Period Cash Flow | 3 M | |
| Total Cashflows From Investing Activities | 2.7 M |
Regencell | Build AI portfolio with Regencell Stock |
Regencell Bioscience Relative Risk vs. Return Landscape
If you would invest 1,310 in Regencell Bioscience Holdings on November 5, 2025 and sell it today you would earn a total of 1,518 from holding Regencell Bioscience Holdings or generate 115.88% return on investment over 90 days. Regencell Bioscience Holdings is generating 2.084% of daily returns assuming volatility of 13.4985% on return distribution over 90 days investment horizon. In other words, majority of equities are less volatile than Regencell, and most equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Regencell Bioscience Target Price Odds to finish over Current Price
The tendency of Regencell Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 28.28 | 90 days | 28.28 | about 21.84 |
Based on a normal probability distribution, the odds of Regencell Bioscience to move above the current price in 90 days from now is about 21.84 (This Regencell Bioscience Holdings probability density function shows the probability of Regencell Stock to fall within a particular range of prices over 90 days) .
Regencell Bioscience Price Density |
| Price |
Predictive Modules for Regencell Bioscience
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Regencell Bioscience. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Regencell Bioscience Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Regencell Bioscience is not an exception. The market had few large corrections towards the Regencell Bioscience's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Regencell Bioscience Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Regencell Bioscience within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.40 | |
β | Beta against Dow Jones | 2.03 | |
σ | Overall volatility | 9.36 | |
Ir | Information ratio | 0.11 |
Regencell Bioscience Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Regencell Bioscience for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Regencell Bioscience can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Regencell Bioscience is way too risky over 90 days horizon | |
| Regencell Bioscience appears to be risky and price may revert if volatility continues | |
| Reported Net Loss for the year was (3.58 M) with profit before taxes, overhead, and interest of 0. | |
| Regencell Bioscience Holdings has about 59.41 K in cash with (3.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 89.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from thelincolnianonline.com: Regencell Bioscience Trading Up 12.6 percent Should You Buy |
Regencell Bioscience Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Regencell Stock often depends not only on the future outlook of the current and potential Regencell Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Regencell Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 494.5 M | |
| Cash And Short Term Investments | 4.9 M |
Regencell Bioscience Fundamentals Growth
Regencell Stock prices reflect investors' perceptions of the future prospects and financial health of Regencell Bioscience, and Regencell Bioscience fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Regencell Stock performance.
| Return On Equity | -0.55 | ||||
| Return On Asset | -0.33 | ||||
| Current Valuation | 13.79 B | ||||
| Shares Outstanding | 494.49 M | ||||
| Price To Earning | 26.21 X | ||||
| Price To Book | 2,543 X | ||||
| EBITDA | (3.19 M) | ||||
| Net Income | (3.58 M) | ||||
| Cash And Equivalents | 59.41 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 544.41 K | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 13.94 X | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (3.11 M) | ||||
| Earnings Per Share | (0.01) X | ||||
| Market Capitalization | 12.36 B | ||||
| Total Asset | 5.76 M | ||||
| Retained Earnings | (25.2 M) | ||||
| Working Capital | 7.92 M | ||||
| Current Asset | 438.2 M | ||||
| Current Liabilities | 551.3 M | ||||
About Regencell Bioscience Performance
By analyzing Regencell Bioscience's fundamental ratios, stakeholders can gain valuable insights into Regencell Bioscience's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Regencell Bioscience has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Regencell Bioscience has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (30.84) | (32.38) | |
| Return On Tangible Assets | (0.56) | (0.59) | |
| Return On Capital Employed | (0.85) | (0.81) | |
| Return On Assets | (0.56) | (0.59) | |
| Return On Equity | (0.85) | (0.81) |
Things to note about Regencell Bioscience performance evaluation
Checking the ongoing alerts about Regencell Bioscience for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Regencell Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Regencell Bioscience is way too risky over 90 days horizon | |
| Regencell Bioscience appears to be risky and price may revert if volatility continues | |
| Reported Net Loss for the year was (3.58 M) with profit before taxes, overhead, and interest of 0. | |
| Regencell Bioscience Holdings has about 59.41 K in cash with (3.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 89.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from thelincolnianonline.com: Regencell Bioscience Trading Up 12.6 percent Should You Buy |
- Analyzing Regencell Bioscience's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Regencell Bioscience's stock is overvalued or undervalued compared to its peers.
- Examining Regencell Bioscience's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Regencell Bioscience's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Regencell Bioscience's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Regencell Bioscience's stock. These opinions can provide insight into Regencell Bioscience's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Regencell Stock analysis
When running Regencell Bioscience's price analysis, check to measure Regencell Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regencell Bioscience is operating at the current time. Most of Regencell Bioscience's value examination focuses on studying past and present price action to predict the probability of Regencell Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regencell Bioscience's price. Additionally, you may evaluate how the addition of Regencell Bioscience to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |